Skip to main content

Table 1 Association between LBX2-AS1 protein expression and clinicopathologic characteristics of 265 CRC patients in the study cohort

From: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance

Characteristics No.of LBX2-AS1 protein level P value
Patient High (N = 135) Low (N = 130)
Gender 0.182
 Female 117 65 52  
 Male 148 70 78  
Age (years) 0.641
 < 60 76 37 39  
 ≥ 60 189 98 91  
Tumor location 0.441
 Rectum 118 57 61  
 Colon 147 78 69  
Differentiation grade 0.330
 Well + moderate 201 99 102  
 Poor 64 36 28  
Tumor size (cm) 0.259
 < 5 105 49 56  
 ≥ 5 160 86 74  
Local invasion 0.014
 pT1–T2 201 95 116  
 pT3–T4 64 40 24  
Lymph node metastasis 0.031
 N0 + N1 164 75 89  
 N2 101 60 41  
TNM stage 0.017
 I + II 158 71 87  
 III 107 64 43  
Adjuvant chemotherapy 0.245
 No 76 43 33  
 Yes 189 92 97  
CA19-9(kU/L) 0.251
 < 40 123 58 65  
 ≥ 40 142 77 65  
Serum CEA level (ng/mL) 0.730
 < 10 117 61 56  
 ≥ 10 148 74 74  
  1. Bold type indicates statistical significance